서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2023-02	INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M.; Martin, Andrew J.; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J.; Tebbutt, Niall C.; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David BMC Cancer, Vol.23 No.1, p. 12885	DOI
2023-02	INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M.; Martin, Andrew J.; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O’Callaghan, Christopher J.; Tebbutt, Niall C.; Hague, Wendy; Chan, Howard; Rha, Sun Y.; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David BMC Cancer, 23(1):180	view file DOI
2025-02	INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin; Martin, Andrew; Jaworski, Anthony; Tebbutt, Niall; Bang, Yung-Jue; Alcindor, Thierry; O'Callaghan, Chris; Strickland, Andrew; Rha, Sun Young; Lee, Keun-Wook; Kim, Jin-Soo; Bai, Li-Yuan; Hara, Hiroki; Oh, Do Youn; Yip, Sonia; Zalcberg, John; Price, Tim; Simes, John; Goldstein, David Journal of Clinical Oncology, Vol.43 No.4, pp.453-463	DOI

1